Advertisement

Topics

BRIEF-Ardelyx to present findings from phase 2b trial of Tenapanor

04:19 EDT 19 Oct 2016 | Reuters

* Ardelyx announces the presentation of positive global endpoint findings from phase 2b trial of Tenapanor in patients with IBS-C at ACG annual meeting

Original Article: BRIEF-Ardelyx to present findings from phase 2b trial of Tenapanor

NEXT ARTICLE

More From BioPortfolio on "BRIEF-Ardelyx to present findings from phase 2b trial of Tenapanor"

Quick Search
Advertisement
 

Relevant Topic

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...